Emanuele Valeriani
Overview
Explore the profile of Emanuele Valeriani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
670
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cammisotto V, Valeriani E, Pignatelli P, Violi F
Antioxidants (Basel)
. 2025 Jan;
14(1.
PMID: 39857417
Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by lipid accumulation in the liver due to an excess in their supplies or an impairment in their management. While some patients...
2.
Girardi L, Di Nisio M, Candeloro M, Valeriani E, Ageno W
Eur J Clin Invest
. 2024 Sep;
55(1):e14311.
PMID: 39262322
Background: Catheter-related thrombosis (CRT) is one of the major complications affecting patients with indwelling venous catheters, usually involving the upper extremity deep venous system. This condition can lead to potentially...
3.
Cappannoli L, Galli M, Borovac J, Valeriani E, Animati F, Fracassi F, et al.
Front Cardiovasc Med
. 2024 Aug;
11:1469413.
PMID: 39211770
No abstract available.
4.
Valeriani E, Pannunzio A, Palumbo I, Bartimoccia S, Cammisotto V, Castellani V, et al.
J Thromb Haemost
. 2024 Jul;
22(10):2823-2833.
PMID: 38971499
Background: Albumin has antiplatelet and anticoagulant functions. Hypoalbuminemia, as defined by serum values of <3.5 g/dL, is associated with arterial thrombosis; its impact on venous thromboembolism (VTE) is unclear. Objectives:...
5.
Violi F, Pignatelli P, Valeriani E
Kardiol Pol
. 2024 Jun;
82(7-8):689-691.
PMID: 38845438
No abstract available.
6.
Valeriani E, Falletta A, Pastori D, Porfidia A, Mastroianni C, Di Bari S, et al.
Eur J Clin Invest
. 2024 Apr;
54(9):e14225.
PMID: 38632681
Background: Midregional-proAdrenomedullin (MR-proADM) has been recently proposed as a tool in patients with sepsis and septic shock. Our aim was to evaluate the prognostic role of MR-proADM in hospitalized patients...
7.
Valeriani E, Cangemi R, Carnevale R, Romiti G, Pannunzio A, Pignatelli P, et al.
Int J Cardiol
. 2024 Mar;
404:131942.
PMID: 38458384
Background: Hypoalbuminemia complicates acute diseases and infections and is associated with a worst prognosis. The aim is to evaluate whether hypoalbuminemia is associated with higher incidence and risk of thrombotic...
8.
Santini P, Mosoni C, DErrico A, Porceddu E, Lupascu A, Valeriani E, et al.
J Clin Med
. 2023 Oct;
12(19).
PMID: 37835070
Background: The way in which to prevent recurrent venous thromboembolism (VTE) is an unmet clinical need in cancer patients. International guidelines only provide conditional recommendations and do not specify which...
9.
Valeriani E, Bartimoccia S, Pignatelli P, Pastori D
Antioxid Redox Signal
. 2023 Sep;
41(7-9):542-556.
PMID: 37742116
Several aging-related pathophysiological mechanisms have been described to contribute to increased thrombotic risk in the elderly, including oxidative stress, endothelial dysfunction, and platelet and coagulation cascade activation. Antithrombotic treatment in...
10.
Menichelli D, Cormaci V, Marucci S, Franchino G, Del Sole F, Capozza A, et al.
Autoimmun Rev
. 2023 Sep;
22(11):103447.
PMID: 37714419
Autoimmune diseases have specific pathophysiologic mechanisms leading to an increased risk of arterial and venous thrombosis. The risk of venous thromboembolism (VTE) varies according to the type and stage of...